NCX-4016, A NOVEL ACETYLSALICYLIC-ACID NITRO DERIVATIVE, INHIBITS PLATELET-AGGREGATION IN-VITRO AND PULMONARY THROMBOEMBOLISM IN MICE AND RABBITS MORE EFFECTIVELY THAN ASPIRIN
S. Momi et al., NCX-4016, A NOVEL ACETYLSALICYLIC-ACID NITRO DERIVATIVE, INHIBITS PLATELET-AGGREGATION IN-VITRO AND PULMONARY THROMBOEMBOLISM IN MICE AND RABBITS MORE EFFECTIVELY THAN ASPIRIN, Thrombosis research, 91(3), 1998, pp. 37-37